RIPK1 and amyotrophic lateral sclerosis: These data suggest a preferentially abnormal activation of RIPK1 and necroptosis in ALS with bulbar onset and ALS with more severe bulbar symptoms and also increased IL-8 in peripheral as a biomarker for inflammation in ALS.